Long-Term Spinal Opioid Therapy
in Terminally Ill Cancer Pain Patients
by
Wagemans MF, Zuurmond WW, de Lange JJ
Department of Anesthesiology,
Academic Hospital "Vrije Universiteit,"
1007 MB Amsterdam,
The Netherlands.
Oncologist 1997; 2(2):70-75

ABSTRACT

In terminally ill cancer patients with refractory pain, long-term spinal opioid therapy may provide a profound analgesia with minimal side effects. The reversibility of the technique and its efficacy throughout the body and for different types of pain are important advantages. For epidural administration, it is preferable to use lipid soluble opioids (sufentanil). For intrathecal administration, morphine is the best choice. The advantages of intrathecal administration over epidural administration are the need for lower doses because of a more direct administration at the receptor site, the easy positioning of the catheter, and less risk for migration of the catheter. In severe refractory pain which does not respond to spinal opioids, the use of non-opioids (e.g., a local anesthetic or an alpha-2 adrenoreceptor agonist) as coanalgesics may be recommended for improving pain relief. Long-term spinal opioid therapy at home has been made possible by technical and organizational development. In home care, only one physician should be the manager for the patient. Coordination should be optimized among patient, family, general practitioner, oncologist, anesthesiologist, home nurse, technician, and pharmacist.

Mu
Pain
LAAM
Heroin
Tramadol
Tolerance
Feline mania
Endomorphins
Intravenous rush
Drugs versus cash
Fentanyl and ketamine
Is morphine a smart drug?
Opioids, mood and cognition
Is morphine an antidepressant?
Depression, opioids and the HPA
Methadone, morphine and heroin
Kappa upregulation and addiction
Opioids, depression and learned helplessness
Morphine as a neurotransmitter/neuromodulator

Refs
HOME
HedWeb
Cannabis.net
BLTC Research
Designer Drugs
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?